Wellness products company Nature’s Sunshine Products (NASDAQ:NATR) will be reporting earnings tomorrow after market hours. Here’s what investors should know.
Nature's Sunshine missed analysts’ revenue expectations by 1.6% last quarter, reporting revenues of $110.6 million, down 5.1% year on year. It was a softer quarter for the company, with full-year revenue guidance missing analysts’ expectations and a miss of analysts’ earnings estimates.
Is Nature's Sunshine a buy or sell going into earnings? Read our full analysis here, it’s free.
This quarter, analysts are expecting Nature's Sunshine’s revenue to decline 2% year on year to $108.9 million, a reversal from the 6.4% increase it recorded in the same quarter last year. Adjusted earnings are expected to come in at $0.14 per share.
The majority of analysts covering the company have reconfirmed their estimates over the last 30 days, suggesting they anticipate the business to stay the course heading into earnings. Nature's Sunshine has missed Wall Street’s revenue estimates three times over the last two years.
Looking at Nature's Sunshine’s peers in the personal care segment, some have already reported their Q3 results, giving us a hint as to what we can expect. Herbalife’s revenues decreased 3.2% year on year, missing analysts’ expectations by 1%, and Medifast reported a revenue decline of 40.6%, topping estimates by 1.5%. Herbalife traded up 10.2% following the results while Medifast was also up 8.6%.
Read our full analysis of Herbalife’s results here and Medifast’s results here.
Investors in the personal care segment have had steady hands going into earnings, with share prices up 1.2% on average over the last month. Nature's Sunshine’s stock price was unchanged during the same time and is heading into earnings with an average analyst price target of $19.50 (compared to the current share price of $13.07).
Today’s young investors won’t have read the timeless lessons in Gorilla Game: Picking Winners In High Technology because it was written more than 20 years ago when Microsoft and Apple were first establishing their supremacy. But if we apply the same principles, then enterprise software stocks leveraging their own generative AI capabilities may well be the Gorillas of the future. So, in that spirit, we are excited to present our Special Free Report on a profitable, fast-growing enterprise software stock that is already riding the automation wave and looking to catch the generative AI next.
